Interaction of multitargeted tyrosine kinase inhibitors with human nucleoside transporters

被引：0
|
作者：
Damaraju, Vijaya L. [1 ]
Kuzma, Michelle [1 ]
Mowles, Delores [1 ]
Cass, Carol E. [2 ]
Sawyer, Michael B. [1 ]
机构：
[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[2] Univ Alberta, Edmonton, AB, Canada
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-797
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
797
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors
    C Lemos
    G Jansen
    G J Peters
    British Journal of Cancer, 2008, 98 : 857 - 862
  • [22] Drug transporters: Recent advances concerning BCRP and tyrosine kinase inhibitors
    Lemos, C.
    Jansen, G.
    Peters, G. J.
    BRITISH JOURNAL OF CANCER, 2008, 98 (05) : 857 - 862
  • [23] Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes
    Chang, Wei-Ting
    Liu, Ping-Yen
    Lee, Kaisen
    Feng, Yin-Hsun
    Wu, Sheng-Nan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (05)
  • [24] Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2
    Miller, Siennah R.
    Hau, Raymond K.
    Jilek, Joseph L.
    Morales, Mark N.
    Wright, Stephen H.
    Cherrington, Nathan J.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (07) : 603 - 612
  • [25] Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib
    S. E. Rosenbaum
    S. Wu
    M. A. Newman
    D. P. West
    T. Kuzel
    M. E. Lacouture
    Supportive Care in Cancer, 2008, 16 : 557 - 566
  • [26] Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib
    Rosenbaum, S. E.
    Wu, S.
    Newman, M. A.
    West, D. P.
    Kuzel, T.
    Lacouture, M. E.
    SUPPORTIVE CARE IN CANCER, 2008, 16 (06) : 557 - 566
  • [27] Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?
    Hegedus, Csilla
    Oezvegy-Laczka, Csilla
    Szakacs, Gergely
    Sarkadi, Balazs
    CURRENT CANCER DRUG TARGETS, 2009, 9 (03) : 252 - 272
  • [28] Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors IDENTIFICATION OF KEY hENT1 AMINO ACID RESIDUES FOR INTERACTION WITH BCR-ABL KINASE INHIBITORS
    Damaraju, Vijaya L.
    Weber, Dwayne
    Kuzma, Michelle
    Cass, Carol E.
    Sawyer, Michael B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (36) : 18809 - 18817
  • [29] Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
    Scagliotti, Giorgio
    Govindan, Ramaswamy
    ONCOLOGIST, 2010, 15 (05): : 436 - 446
  • [30] Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors
    Yuan, Anna
    Kurtz, Sharyn L.
    Barysauskas, Constance M.
    Pilotte, Amy P.
    Wagner, Andrew J.
    Treister, Nathaniel S.
    ORAL ONCOLOGY, 2015, 51 (11) : 1026 - 1033
12345